☆ 4.3 Article

Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2023)

Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy

Francisco Raposo et al.

Summary: This study examined the antibody response in individuals who received an overdose of the BNT162b2 vaccine, finding that despite the overdosage, the vaccine was able to elicit a significant antibody response. The findings suggest that the prime-dose of the vaccine is sufficient to trigger an effective antibody response.

CLINICA CHIMICA ACTA (2021)

添加到收藏夹

Letter Medicine, General & Internal

Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex

Noa Dagan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

D. Mevorach et al.

Summary: The incidence of myocarditis increased after receiving the BNT162b2 vaccine in Israel, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Annette B. Vogel et al.

Summary: The two vaccine candidates, BNT162b1 and BNT162b2, developed contain modified messenger RNA encoding immunogens derived from the spike glycoprotein of SARS-CoV-2. They have shown promising immune responses in mice and rhesus macaques, with ongoing phase I trials in Germany and the USA and a global phase II/III trial for BNT162b2.

NATURE (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Robert W. Frenck et al.

Summary: The BNT162b2 vaccine showed favorable safety profile and a greater immune response in 12-to-15-year-old recipients compared to young adults, and demonstrated high effectiveness against Covid-19.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Safety and antibody response of recipients who unexpectedly received undiluted prime dose of BNT162b2 COVID-19 vaccine in Taiwan

相关参考文献

Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy

Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

导出引文

分享论文